Bohring-Opitz Syndrome

Bohring-Opitz syndrome is a very rare genetic condition caused most often by a new (not inherited) change in the ASXL1 gene. Babies usually have trouble feeding and growing, a special body posture (arms bent and wrists flexed), sleep apnea, and delayed development. Seizures can happen but often respond to usual anti-seizure medicines. Many children have vision issues (often severe nearsightedness) and facial features like prominent eyes and a small lower jaw. Doctors watch closely for vomiting, aspiration, infections, and breathing problems. Routine kidney (renal) ultrasounds every 3 months from birth to age 8 are advised because BOS has a small but real link with Wilms tumor (a childhood kidney cancer). NCBI

Bohring-Opitz syndrome is a very rare genetic condition that affects growth and development of many body systems from birth. Most babies have feeding problems, slow growth, and severe developmental delay. Many have a very characteristic body posture in early life, with bent elbows and wrists turned toward the little finger side. Doctors often notice distinctive facial features, and some children develop seizures, sleep apnea, or recurrent infections. BOS happens because of a change (variant) in a single gene called ASXL1. The change is usually new in the child and not present in either parent. NCBI+2MedlinePlus+2

---

Other names

BOS is also called Oberklaid-Danks syndrome, which is an older name you may see in older papers and websites. You may also see abbreviations like BOPS in some databases. All of these refer to the same condition linked to ASXL1. NCBI+1

---

Types

There are no official medical subtypes of Bohring-Opitz syndrome. However, doctors sometimes use descriptive labels to explain differences between people:

1. Classic, congenital BOS. Signs are apparent at birth or soon after, including feeding difficulty, slow growth, BOS posture, and the typical facial features. NCBI

2. Mosaic BOS. The ASXL1 change is present in only some cells. Features may be milder or asymmetric. Mosaicism has been documented in parents and children and helps explain variable severity. NCBI+1

3. BOS spectrum by variant type and location. Most people have truncating (stop-early) ASXL1 variants; where the variant sits in the gene, and whether it escapes cellular “quality control,” can influence how the protein misfunctions and how severe the condition is. NCBI

4. BOS with tumor risk. A small subset have an increased risk of Wilms tumor (a childhood kidney cancer), so tumor screening is recommended in early childhood. NCBI+1

---

Causes

Although “cause” often means many things, for BOS the cause is genetic. Below are 20 ways scientists and clinicians talk about the single underlying cause and its mechanisms:

1. A new (de novo) change in ASXL1. In most children, the ASXL1 variant starts in the egg or sperm or very early after conception, so neither parent has it. NCBI

2. Autosomal-dominant effect. One changed copy of ASXL1 in each cell is enough to cause the syndrome. NCBI

3. Truncating variants (nonsense or frameshift). Most variants make the ASXL1 protein stop early and not work properly. NCBI

4. Variants in the last part of the gene. Many truncating variants occur late in the gene and may escape the cell’s “stop-error” cleanup system, leaving a shortened protein that can misdirect gene control. NCBI

5. Loss of normal ASXL1 activity (haploinsufficiency or dominant-negative effect). Having less working ASXL1—or a shortened protein that interferes—disturbs gene regulation during development. PubMed

6. Mosaicism in the child. If only some cells carry the variant, features may be milder or patchy. NCBI

7. Parental germline mosaicism. A parent can carry the variant in a small fraction of egg or sperm cells without showing signs, which can very rarely lead to more than one affected child. NCBI

8. Splice-site variants. Some variants disrupt how the gene’s message is cut and pasted, leading to faulty protein. NCBI

9. Very small deletions/duplications. Changes removing or adding just a bit of ASXL1 can also disturb its function. (These are less common but checked when sequencing is negative.) NCBI

10. Balanced rearrangements disrupting ASXL1. Rarely, a chromosome break near ASXL1 can interrupt the gene. NCBI

11. Disrupted Polycomb/epigenetic control. ASXL1 helps control how DNA is packaged and which genes turn on or off. When ASXL1 is abnormal, this “epigenetic” control is disturbed. PubMed+1

12. Altered PR-DUB/PRC signaling. ASXL1 works with chromatin complexes that add/remove specific chemical tags on histones; variants disturb these tags and gene activity. Abcam+1

13. Abnormal control of developmental genes (e.g., HOX). Faulty ASXL1 can mis-regulate genes that shape the body plan, contributing to BOS features. PubMed

14. DNA methylation signature. People with BOS show a distinct “episignature” on DNA methylation testing, reflecting a shared molecular effect of ASXL1 variants. PMC+1

15. Exome/genome-negative BOS-like presentations. Sometimes a child looks like BOS but standard tests are negative; broader testing or methylation profiling may reveal the ASXL1 mechanism. NCBI+1

16. Atypical or milder variants. Some ASXL1 variants cause a BOS-like picture that is less typical (e.g., less obvious posture), showing a range of effects from one gene. NCBI

17. Pathogenic variant inherited from a mosaic parent. Rarely, a parent with germline mosaicism can pass the variant on even if that parent looks unaffected. PubMed

18. Interaction with other genes. The ASXL1 pathway connects to many chromatin regulators; disturbances here can modify severity, helping explain why BOS looks different from child to child. Frontiers

19. Not caused by pregnancy exposures. There is no evidence that medicines, foods, or infections during pregnancy cause BOS; it is a genetic condition. NCBI

20. Not typically inherited across generations. Adults with classic BOS rarely reproduce; most cases are one-time events in the family, with a small recurrence risk from parental mosaicism. NCBI

---

Common symptoms and clinical features

1. Severe developmental delay or intellectual disability. Most children learn slowly and need long-term support for speech, motor, and daily skills. NCBI+1

2. Minimal or absent spoken language. Many children communicate best with gestures, pictures, or devices. NCBI

3. Feeding difficulty and vomiting. Reflux, choking, and poor weight gain are common in infancy; feeding tubes are sometimes needed. NCBI

4. Poor growth (failure to thrive). Weight and height often track low on growth charts. NCBI

5. Typical BOS posture. Early in life, elbows are bent, wrists flexed and tilted toward the little finger, with floppy trunk tone and tighter arms and legs. This often softens with age. NCBI

6. Distinctive facial appearance. Features may include small or triangular forehead shape (trigonocephaly), a visible pink birthmark between the eyebrows or on the eyelids (nevus simplex), prominent eyes, and small jaw. NCBI+1

7. Seizures. Seizures can begin in infancy or childhood and are managed with standard anti-seizure medicines. NCBI

8. Sleep problems and obstructive sleep apnea. Snoring, pauses in breathing, or restless sleep are common and should be checked. NCBI

9. Low muscle tone of the trunk with tight limbs. This mix affects posture and movement and benefits from physical therapy. NCBI

10. Vision issues. High myopia and other eye findings can occur and need early ophthalmology care. NCBI

11. Recurrent infections in early childhood. These often improve as children grow. NCBI

12. Heart differences. Minor heart anomalies can be present and usually need an echocardiogram check. NCBI

13. Kidney differences and tumor risk. A small but real risk of Wilms tumor exists; kidney ultrasound screening is recommended in early childhood. NCBI+1

14. Scoliosis or joint contractures. Spine curvature and tight joints can develop and call for orthopedic and therapy support. NCBI

15. Behavioral and sensory challenges. Many children have sensory sensitivities and benefit from occupational therapy and structured routines. NCBI

---

Diagnostic tests

A) Physical examination

1. Comprehensive dysmorphology exam. A clinical geneticist looks for the BOS posture; facial features such as trigonocephaly, nevus simplex, prominent eyes; and signs of feeding difficulty. This careful head-to-toe exam guides which lab tests to order first. NCBI

2. Growth and head measurements. Length/height, weight, and head circumference help document growth restriction or microcephaly and track nutrition over time. NCBI

3. Neurologic exam. The doctor checks tone, reflexes, posture, and movement patterns to document truncal hypotonia with limb hypertonia and to look for signs that raise the suspicion of seizures. NCBI

4. Eye examination (bedside screening before referral). Basic checks for eye alignment and visual tracking can flag early problems and prompt rapid referral to ophthalmology. NCBI

5. Cardiorespiratory assessment. Listening for murmurs and watching for apnea or noisy breathing helps prioritize heart echo and sleep studies. NCBI

B) Manual and functional tests (5 tests)

6. Standardized developmental testing (e.g., Bayley Scales). This measures motor, language, and cognitive skills to plan early intervention and therapies. NCBI

7. Feeding and swallowing evaluation. A speech-language pathologist assesses suck-swallow-breathe coordination, reflux symptoms, and aspiration risk to guide feeding therapy or the need for a tube. NCBI

8. Sleep questionnaires and clinic screening. Simple tools (parent forms) identify children at risk for obstructive sleep apnea who need a formal sleep study. NCBI

9. Physical therapy motor evaluation (e.g., HINE/PDMS-2). A therapist measures posture, range of motion, and motor milestones to design a stretching and strengthening plan. NCBI

10. Orthopedic goniometry and spine screening. Measuring joint range and checking for scoliosis or contractures helps time bracing, therapy, or imaging. NCBI

C) Laboratory and pathological tests (5 tests)

11. ASXL1 sequencing (single-gene). This is the main test and looks for a disease-causing change in ASXL1. If found, it confirms the diagnosis. If not found and suspicion remains, deletion/duplication analysis is the next step. NCBI

12. Deletion/duplication testing of ASXL1. This checks for very small missing or extra pieces affecting ASXL1 that routine sequencing can miss. NCBI

13. Trio exome or genome sequencing. When single-gene testing is negative, testing the child and both parents together increases the chance of finding a de novo ASXL1 variant or another look-alike condition. NCBI

14. DNA methylation “episignature” testing. BOS has a recognizable methylation pattern in blood; this test can support a diagnosis and help classify uncertain ASXL1 variants. PMC+1

15. General labs for complications. A complete blood count and chemistry panel help monitor nutrition, infections, and medication effects during care. (These do not diagnose BOS but support overall management.) NCBI

D) Electrodiagnostic tests (2 tests)

16. Electroencephalogram (EEG). If seizures are suspected, EEG helps confirm them and guides treatment choices. NCBI

17. Overnight sleep study (polysomnography). This detects obstructive sleep apnea, which is common in BOS and treatable. NCBI

E) Imaging tests (3 tests)

18. Brain MRI. MRI looks for structural differences that may relate to seizures or tone problems and helps rule out other causes. NCBI

19. Kidney ultrasound (with tumor screening schedule). Because BOS carries a small risk of Wilms tumor, kidney ultrasound is recommended every three months from birth to age eight to catch tumors early when they are most treatable. NCBI+1

20. Echocardiogram. An ultrasound of the heart checks for minor congenital differences that sometimes occur in BOS. NCBI

---

Non-pharmacological treatments (therapies & other supports)

Note: These are tailored by a multidisciplinary team (genetics, neurology, gastroenterology, pulmonology/sleep, nutrition, ophthalmology, therapy services). None of these cures BOS; they improve safety, comfort, growth, learning, and participation. NCBI+1

1) Feeding therapy (oral-motor & swallowing training)
A speech-language pathologist helps babies learn safer sucking, swallowing, and pacing to reduce choking, vomiting, and aspiration. Sessions focus on posture, nipple/flow choice, and texture advancement. Safer feeding lowers hospital visits and helps weight gain. Mechanism: graded sensory-motor practice improves the timing and strength of tongue, lip, and pharyngeal movements while compensatory strategies (chin tuck, pacing) reduce airway entry of feeds. NCBI

2) Thickened feeds & positioning
Using thickened liquids and upright or side-lying positions can reduce reflux and aspiration. Parents are trained to keep the baby upright after feeds and to recognize stress cues. Mechanism: thicker fluids flow more slowly and are easier to control; upright posture reduces retrograde flow into the esophagus and airway. NCBI

3) Gastrostomy (G-tube) care planning & home feeding routines
When oral feeding is unsafe or inadequate, a G-tube (or GJ-tube) supports nutrition, growth, and reduces aspiration risk. Families learn pump use, venting, and infection prevention. Mechanism: bypassing oral phase prevents aspiration events and ensures reliable calorie delivery. (The device itself is surgical; here the focus is on ongoing non-drug care.) NCBI

4) Sleep hygiene & noninvasive ventilation (CPAP/BiPAP) training
Because obstructive sleep apnea is common, caregivers learn sleep-positioning, nasal care, and mask desensitization; CPAP/BiPAP may be used if prescribed. Mechanism: positive airway pressure splints the upper airway, preventing collapse and improving oxygen and CO₂ control overnight. NCBI

5) Physical therapy (PT)
PT targets trunk hypotonia with extremity hypertonia. Gentle stretching, supported sitting, and weight-bearing help posture, comfort, and contracture prevention. Mechanism: neurodevelopmental techniques and regular range-of-motion reduce spastic patterns and maintain joint mobility. NCBI

6) Occupational therapy (OT)
OT adapts daily routines, seating, and hand use. Splints may counter wrist/hand flexion; custom seating improves breathing and feeding posture. Mechanism: task-specific practice and adaptive equipment build participation and safety. NCBI

7) Vision services & protective strategies
Early eye exams address high myopia and retinal/optic nerve issues; glasses and environmental adaptations (contrast, lighting) prevent falls and improve learning. Mechanism: correcting refractive error and optimizing visual input support development. NCBI

8) Early intervention & special education
State/local programs provide family-centered developmental therapy, communication supports, and individualized education plans—key for severe expressive language delay. Mechanism: enriched, repetitive learning strengthens alternative communication pathways. NCBI

9) Aspiration precautions & respiratory physiotherapy
Airway clearance routines (percussion, suction training when appropriate) and careful illness plans reduce pneumonia risk. Mechanism: mobilizing secretions and reducing aspiration events protect lungs. NCBI

10) Dental/oral care program
Early dental visits, fluoride, and oral-motor routines lower caries risk in children with feeding difficulties and reflux. Mechanism: neutralizing acid exposure and plaque control. NCBI

11) Tumor surveillance protocol
Renal ultrasound every 3 months from birth to age 8; some experts add liver views given emerging registry data. Families learn red flags (abdominal mass, hematuria). Mechanism: screening detects tumors earlier when outcomes are better. NCBI+2NCBI+2

12) Craniofacial team evaluation
High-arched/cleft palate and micrognathia affect feeding, speech, and airway. A coordinated team (ENT, dental, plastic surgery, SLP) plans timing of palate repair or mandibular interventions as needed. Mechanism: structural optimization of airway and resonance. NCBI

13) Seizure safety education
Families learn seizure first-aid, rescue plans, and monitoring strategies; school plans include medication access. Mechanism: rapid, organized response reduces injury and status epilepticus risk. NCBI

14) Behavioral & communication supports
Augmentative/alternative communication (AAC) and structured routines lower frustration when expressive speech is limited. Mechanism: external communication aids replace weak verbal output. NCBI

15) Growth & nutrition monitoring
Dietitians individualize calories, protein, and micronutrients; they manage constipation with fiber/fluids and adjust formulas for reflux. Mechanism: targeted nutrition restores energy balance and tissue repair. NCBI

16) Infection-prevention coaching
Hand hygiene, vaccines, and early care for UTIs/respiratory infections are emphasized because infections are common in early childhood (often improving with age). Mechanism: lowering exposure and boosting immune protection reduces hospitalizations. NCBI

17) Orthotics & positioning devices
Wrist/hand splints, ankle-foot orthoses, and customized seating improve posture and function, and help with the characteristic BOS upper-limb posture. Mechanism: external alignment counters deforming forces. NCBI

18) Caregiver training & respite planning
Structured teaching for feeds, devices, airway care, and emergency signs prevents crises and burnout. Mechanism: empowered caregivers detect problems earlier and follow safer routines. NCBI

19) Regular ophthalmology & hearing checks
Because vision issues are common and may worsen in infancy, scheduled exams are critical; hearing assessments support language planning. Mechanism: correcting sensory deficits maximizes neurodevelopment. NCBI

20) Genetics counseling for family planning
Most cases are de novo, but counseling addresses recurrence risk (including parental mosaicism) and testing options. Mechanism: informed reproductive decisions and earlier diagnosis. NCBI

---

Drug treatments

Important: No drug treats the genetic cause of BOS. Medicines below are commonly used for symptoms seen in BOS (e.g., seizures, reflux, drooling, constipation). Doses are individualized by the child’s clinician. Label citations are provided from accessdata.fda.gov when available. NCBI

1) Levetiracetam (Keppra/Spritam) – anti-seizure
Often chosen for pediatric seizures due to broad spectrum and ease of use. Typical pediatric dosing is weight-based with slow titration; available as tablet, liquid, ODT, and IV. Purpose: reduce seizure frequency and prevent status epilepticus. Mechanism: modulates synaptic vesicle protein SV2A to decrease neuronal excitability. Side effects can include irritability, somnolence, and behavioral changes; abrupt stop is avoided. FDA Access Data+2FDA Access Data+2

2) Valproate (divalproex/valproic acid; Depakote/Depakene) – anti-seizure
Useful for generalized seizures; dosing is weight-based with serum level monitoring. Purpose: broad seizure control when other agents are insufficient. Mechanism: increases GABA and reduces neuronal firing. Key warnings: hepatotoxicity (especially <2 years), pancreatitis, teratogenicity; regular liver function and platelets are monitored. FDA Access Data+2FDA Access Data+2

3) Topiramate (Topamax) – anti-seizure
Weight-based dosing with slow titration to reduce cognitive slowing and paresthesias. Purpose: adjunctive control of focal/generalized seizures. Mechanism: blocks sodium channels, enhances GABA, antagonizes AMPA/kainate receptors, weak carbonic anhydrase inhibition. Watch for kidney stones, appetite/weight change, and metabolic acidosis. FDA Access Data

4) Lamotrigine (Lamictal) – anti-seizure
Titrated slowly to reduce rash risk; useful for focal and generalized seizures. Purpose: seizure reduction with favorable cognitive profile. Mechanism: inhibits voltage-gated sodium channels to stabilize neuronal membranes. Boxed warning: serious skin rashes (Stevens-Johnson). FDA Access Data

5) Clonazepam (Klonopin) – benzodiazepine for seizures/myoclonus
Intermittent or maintenance use for certain seizure types or hypertonia bursts. Mechanism: enhances GABA-A inhibition. Side effects: sedation, tolerance, dependence; taper to discontinue. FDA Access Data+1

6) Omeprazole (Prilosec) – reflux (GERD)
Children with severe reflux/vomiting may receive a PPI trial; dosing is weight-based. Purpose: reduce esophageal injury, pain, and aspiration risk. Mechanism: blocks proton pumps in parietal cells to lower acid. Consider lowest effective dose and step-down when possible. FDA Access Data+1

7) Metoclopramide (Reglan/ODT; Gimoti nasal) – prokinetic/antiemetic
Selected cases with refractory emesis might use short courses; boxed warning: tardive dyskinesia—avoid chronic use. Purpose: enhance gastric emptying and reduce vomiting. Mechanism: dopamine-2 antagonism and 5-HT4 activity increase GI motility. FDA Access Data+2FDA Access Data+2

8) Glycopyrrolate oral solution (Cuvposa) – drooling (sialorrhea)
For chronic severe drooling in neurologic conditions; weight-based dosing with titration. Purpose: reduce aspiration risk and skin breakdown from drooling. Mechanism: anticholinergic reduction of salivary flow. Side effects: constipation, urinary retention, blurred vision. FDA Access Data

9) Polyethylene glycol 3350 (PEG 3350) – constipation
Used to soften stool and improve regularity; dose individualized (often daily). Purpose: relieve constipation worsened by low mobility and medications. Mechanism: osmotic water retention in stool; minimal systemic absorption. (Bowel-prep PEG/electrolyte labels shown here; consumer PEG 3350 powder is also FDA-listed OTC.) FDA Access Data+2FDA Access Data+2

10) Baclofen (oral solutions: Ozobax, Fleqsuvy; granules: Lyvispah) – spasticity
For hypertonia of extremities that interferes with care or comfort. Purpose: reduce muscle over-activity and ease stretching/positioning. Mechanism: GABA-B agonist reducing spinal reflexes. Monitor for drowsiness and, with intrathecal forms, avoid abrupt withdrawal. Dose is weight-based and titrated slowly. FDA Access Data+2FDA Access Data+2

---

Dietary molecula supplements

Supplements do not treat BOS. They are considered when labs or diet show deficiencies or specific needs. Always coordinate with the child’s clinicians and dietitian. Citations below are NIH Office of Dietary Supplements (ODS) fact sheets for safe, evidence-based reference ranges and cautions. Office of Dietary Supplements

1) Vitamin D
Used when deficiency is documented to support bone health in low-mobility children or those on anti-seizure drugs. Typical dosing follows pediatric guidelines and 25-OH-D levels; excess can be toxic (hypercalcemia). Mechanism: regulates calcium/phosphate, bone mineralization, and immune signaling. Office of Dietary Supplements

2) Iron
Given only for iron-deficiency anemia (confirmed by labs). Mechanism: restores hemoglobin production and oxygen delivery; improves energy when anemia is present. Over-supplementation harms; dosing mg/kg/day, with rechecks. Office of Dietary Supplements

3) Omega-3 fatty acids (EPA/DHA)
Considered for general cardiometabolic support and potential neurodevelopmental benefits, though evidence for BOS is lacking. Mechanism: membrane fluidity, anti-inflammatory eicosanoid balance. Monitor for GI upset and bleeding risk at high doses. Office of Dietary Supplements

4) Calcium
Only if intake is low or if vitamin D therapy is initiated and diet is inadequate. Mechanism: bone mineralization; works with vitamin D. Excess can cause constipation and kidney stones. Office of Dietary Supplements

5) Probiotics
Sometimes used for antibiotic-associated diarrhea or gut comfort; product-specific evidence varies. Mechanism: microbiome modulation; strains differ in effects. Avoid in severely immunocompromised hosts. Office of Dietary Supplements

6) Multivitamin
Low-dose preparations may cover gaps in selective eaters or G-tube formulas lacking certain micronutrients. Mechanism: broad micronutrient repletion; avoid duplicating single-nutrient supplements. Office of Dietary Supplements

7) Vitamin B12
Used for documented deficiency or malabsorption; supports hematologic and neurologic function. Mechanism: cofactor in DNA synthesis and myelin maintenance. Test before treating. Office of Dietary Supplements

8) Folate (Vitamin B9)
Given only with proven deficiency; excess can mask B12 deficiency. Mechanism: one-carbon metabolism critical for hematopoiesis. Office of Dietary Supplements

9) Magnesium
Consider for constipation (as clinician-directed) or if deficient. Mechanism: neuromuscular stability and stool softening (osmotic effect). Office of Dietary Supplements

10) Zinc
For diagnosed deficiency with poor growth or recurrent infections. Mechanism: enzyme/cofactor in growth and immune function; excess can lower copper. Office of Dietary Supplements

---

Immunity-booster / regenerative / stem-cell” drugs

There are no approved “immunity-booster,” regenerative, or stem-cell drugs for BOS. That said, selected immunoprophylaxis may be appropriate in infancy:

a) Palivizumab (Synagis) – passive RSV immunization for certain high-risk infants, given monthly during RSV season. Mechanism: monoclonal antibody to RSV F protein to reduce severe RSV disease. Use follows strict criteria; talk with your pediatric pulmonologist. FDA Access Data+1

b) Newer long-acting anti-RSV antibodies (e.g., nirsevimab; and other agents under review) are FDA-approved/under review for specified infant groups, offering single-dose seasonal protection; decisions are individualized. (BOS itself is not an indication; risk is based on clinical status.) FDA Access Data+1

Beyond these, no stem-cell or regenerative therapy has proven benefit or approval for BOS. Families should avoid clinics advertising unproven stem-cell cures. NCBI

---

Surgeries (what they are, and why done)

1) Gastrostomy (G-tube) or gastrojejunostomy (GJ-tube)
Procedure: a feeding tube is placed into the stomach (or advanced to the jejunum). Why: to secure nutrition/hydration, bypass unsafe swallowing, and reduce aspiration and hospitalization from vomiting. NCBI

2) Tracheostomy (selected cases)
Procedure: small tube in the trachea to maintain airway. Why: for repeated aspiration with lung disease or severe sleep apnea not relieved by CPAP/BiPAP or other interventions. NCBI

3) Palate repair (if cleft) / craniofacial procedures
Procedure: surgical closure of cleft palate or mandibular distraction for airway/feeding problems. Why: to improve feeding safety, speech development, and breathing. NCBI

4) Ophthalmologic surgeries (when indicated)
Procedure: procedures for severe refractive or structural problems (case-by-case). Why: to optimize vision and protect the cornea/retina in high myopia. NCBI

5) Hernia repair / orthopedic releases (case-specific)
Procedure: repair inguinal/umbilical hernias; tendon releases for fixed contractures. Why: reduce pain, prevent incarceration (hernias), and improve positioning/skin care (orthopedics). NCBI

---

Preventions

1. Tumor screening: renal ultrasound every 3 months from birth to age 8; escalate promptly for masses, blood in urine, or abdominal swelling. NCBI+1

2. Aspiration prevention: correct positioning, pacing/thickening, and early G-tube consideration when unsafe. NCBI

3. Sleep apnea detection: early sleep study and CPAP/BiPAP if indicated. NCBI

4. Seizure plan: rescue medication access and school action plans. NCBI

5. Vaccinations + RSV prophylaxis (as eligible): keep all routine immunizations up to date; discuss palivizumab/nirsevimab in eligible infants. FDA Access Data+1

6. Infection control: hand hygiene; early treatment of UTIs and chest infections. NCBI

7. Vision protection: regular eye checks and prompt glasses to avoid amblyopia. NCBI

8. Dental prevention: fluoride, routine cleanings, reflux management to protect enamel. NCBI

9. Constipation plan: hydration, fiber, and clinician-guided laxatives (PEG 3350). FDA Access Data

10. Caregiver training & emergency readiness for feeds, devices, and seizures. NCBI

---

When to see a doctor (or urgent care)

• New or worse vomiting, choking, color change with feeds, or signs of aspiration. NCBI

• Apnea, snoring with pauses, daytime sleepiness, or witnessed breathing stops. NCBI

• Seizure lasting >5 minutes, clusters, or new seizure type. NCBI

• Abdominal mass, swelling, blood in urine, or unexplained fever (Wilms tumor red flags). NCBI

• Poor weight gain despite feeding plan, dehydration, or persistent constipation. NCBI

• Eye redness/pain, sudden vision changes, or frequent falls/bumps. NCBI

---

What to eat & what to avoid

Eat/Use:

1. Dietitian-planned formula or blended feeds (oral or via tube) meeting calories/protein. NCBI

2. Adequate fluids to prevent dehydration and constipation; adjust with clinician. NCBI

3. High-calorie additions (as prescribed) to reduce volume burden if vomiting is a problem. NCBI

4. Fiber sources (or fiber-enriched formulas) when constipation is present. NCBI

5. Micronutrients (e.g., vitamin D, iron) only if deficient or directed by labs. Office of Dietary Supplements+1

Avoid/Limit:

1. Thin liquids if aspiration is documented—use clinician-recommended thickeners. NCBI
2. Acidic/spicy triggers if reflux flares; keep upright after feeds. NCBI
3. Unverified supplements claiming cures or “stem-cell” benefits. NCBI
4. Large, rushed feeds—smaller, paced feeds are safer. NCBI
5. High-choking-risk textures until cleared by your feeding therapist. NCBI

---

FAQs

1) Is there a cure for BOS?
No. Care focuses on symptom control, growth, development, and tumor screening. NCBI

2) What gene is involved?
Most cases involve a new, not-inherited change in ASXL1. NCBI

3) Why are kidney ultrasounds so frequent?
Because BOS carries a risk for Wilms tumor; screening every 3 months to age 8 catches tumors earlier. NCBI+1

4) Do seizures get better?
Seizures are common but often respond to standard anti-seizure medicines chosen by a pediatric neurologist. NCBI

5) Why is feeding so hard?
Poor oral-motor control, reflux, and vomiting are common; feeding therapy and sometimes a G-tube help children grow safely. NCBI

6) Is sleep apnea part of BOS?
Yes, obstructive sleep apnea is reported; sleep studies and CPAP/BiPAP or surgery may be needed. NCBI

7) Are there special vaccines?
Routine vaccines are important; some infants may qualify for RSV monoclonal antibody prophylaxis during RSV season. FDA Access Data+1

8) Will my child walk or talk?
Developmental outcomes vary; expressive speech is often very limited, so early AAC and therapies are key. NCBI

9) What about vision?
High myopia and other eye issues are common; early and regular ophthalmology care is essential. NCBI

10) Are supplements helpful?
Only for proven deficiencies (e.g., vitamin D, iron). There’s no supplement that treats BOS itself. Office of Dietary Supplements+1

11) Does BOS run in families?
Usually no. Most cases are de novo; a genetics visit can discuss rare mosaicism and testing options. NCBI

12) Are there warning signs I should never ignore?
Trouble breathing, blue spells, seizures >5 minutes, a new abdominal mass, or dehydration require urgent care. NCBI

13) Can therapy really help if there’s no cure?
Yes. Therapy improves safety, comfort, and participation, and prevents complications like contractures and aspiration. NCBI

14) Are there research trials?
Clinical trials are limited; your genetics team can help you look for registry studies or symptom-focused trials. NCBI

15) What reputable info sources can I share with family?
GeneReviews (clinician-level), NORD (plain language), and GARD/MedlinePlus provide reliable summaries. MedlinePlus+3NCBI+3National Organization for Rare Disorders+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 29, 2025.